XML 31 R18.htm IDEA: XBRL DOCUMENT v3.26.1
Segment
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Segment

10. Segment

The Company is managed on a consolidated basis with a single reportable segment, chemical manufacturing, which is not an aggregation of individual operating segments. There have been no changes in the basis of segmentation or in the basis of measurement of segment profit or loss since the filing of our 2025 Form 10-K. Information about reported segment revenue, measures of a segment’s profit or loss, significant segment expenses, and measure of a segment's assets:

 

 

Three Months Ended March 31,

 

 

2026

 

2025

 

 

(In Thousands)

Net sales

 

$169,487

 

$143,432

Less:

 

 

 

 

Cost of sales excluding depreciation, amortization
  and turnaround expense

 

108,952

 

106,990

Depreciation and amortization

 

20,847

 

20,063

Turnaround expense

 

3,894

 

1,995

    Total cost of sales

 

133,693

 

129,048

Selling, general and administrative

 

 

 

 

Wages and benefits

 

10,335

 

6,219

   Other selling general and administrative

 

3,490

 

3,934

Total selling general and administrative

 

13,825

 

10,153

Interest expense

 

7,117

 

8,064

(Gain) loss from asset write-down and disposals

 

(1,061)

 

71

Income tax benefit

 

(2,130)

 

(283)

Other segment (income) expense, net (a)

 

(1,642)

 

(1,981)

Segment net income (loss)

 

19,685

 

(1,640)

 

 

 

 

 

Reconciliation of profit or loss

 

 

 

 

Adjustments and reconciling items

 

—

 

—

Consolidated net income (loss)

 

$19,685

 

$(1,640)

_____________________________

(a) For the periods presented, amount consisted primarily of interest and sublease income.

The measure of our chemical manufacturing segment assets is reported on the condensed consolidated balance sheet as total assets. Expenditures for long-lived chemical manufacturing segment assets are reported on our condensed consolidated statement of cash flows.